GLAXOSMITHKLINE FDA Approval NDA 050176

NDA 050176

GLAXOSMITHKLINE

FDA Drug Application

Application #050176

Application Sponsors

NDA 050176GLAXOSMITHKLINE

Marketing Status

Discontinued002

Application Products

002CREAM;TOPICALEQ 3.5MG BASE/GM;10,000 UNITS/GM0NEOSPORINNEOMYCIN SULFATE; POLYMYXIN B SULFATE

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50176
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEOSPORIN","activeIngredients":"NEOMYCIN SULFATE; POLYMYXIN B SULFATE","strength":"EQ 3.5MG BASE\/GM;10,000 UNITS\/GM","dosageForm":"CREAM;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NEOSPORIN","submission":"NEOMYCIN SULFATE; POLYMYXIN B SULFATE","actionType":"EQ 3.5MG BASE\/GM;10,000 UNITS\/GM","submissionClassification":"CREAM;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.